ホーム > 小原 直/ Obara, Naoshi

小原 直

Obara, Naoshi

血液内科 , 教授

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
  1. 1. A Case of Multiple Myeloma in a Patient with Birt-Hogg-Dube Syndrome. Fumiaki Matsumura; Tatsuhiro Sakamoto; Hirayasu Kai; Toshiaki Usui (+15 著者) Mamiko Sakata-Yanagimoto
      Internal medicine (Tokyo, Japan) (2025)
  2. 2. Eltrombopag-Induced Falsely Elevated Bilirubin Concentrations in Enzymatic and Vanadate Oxidation Assays: Involvement of High Serum Eltrombopag Concentrations. Shun Oda; Kosuke Doki; Naoshi Obara; Yoshiharu Suzuki (+1 著者) Masato Homma
      Therapeutic drug monitoring (2025)
  3. 3. Long-term safety and effectiveness of romiplostim for chronic idiopathic thrombocytopenic purpura in real-world settings. Naoshi Obara; Shigeki Hatanaka; Yukie Tsuji; Koji Higashi
      International journal of hematology 120: 665 (2024)
  4. 4. Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment. Zenjiro Sampei; Kenta Haraya; Siok Wan Gan; Masaru Muraoka (+6 著者) Yasutaka Ueda
      International journal of molecular sciences 25: (2024)
  5. 5. Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition. Alexander Röth; Guangsheng He; Hongyan Tong; Zenghua Lin (+23 著者) Bing Han
      American journal of hematology 99: 1768 (2024)
  6. 6. A phase 2, open-label study of ibrutinib plus rituximab in Japanese patients with Waldenstrom's macroglobulinemia. Koji Izutsu; Hisashi Kato; Naohiro Sekiguchi; Tomoaki Fujisaki (+6 著者) Ei Fujikawa
      International journal of hematology 120: 80 (2024) Semantic Scholar
  7. 7. Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide - A retrospective single-center study with a Japanese cohort. Yumiko Maruyama; Hidekazu Nishikii; Naoki Kurita; Tatsuhiro Sakamoto (+6 著者) Shigeru Chiba
      Blood cells, molecules & diseases 105: 102820 (2024) Semantic Scholar
  8. 8. Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors. Naoshi Obara; Kensuke Usuki; Takeshi Hayashi; Masato FujiiTakayuki Ikezoe
      International journal of hematology 119: 255 (2024) Semantic Scholar
  9. 9. [Successful BTK inhibitor therapy for refractory transformed B-cell lymphoma originating from an MYD88 mutant clone]. Atsushi Uehara; Hidekazu Nishikii; Yasuhito Suehara; Ryota Matsuoka (+11 著者) Shigeru Chiba
      [Rinsho ketsueki] The Japanese journal of clinical hematology 65: 1368 (2024)
  10. 10. [Current trends in the treatment of aplastic anemia]. Naoshi Obara
      [Rinsho ketsueki] The Japanese journal of clinical hematology 65: 514 (2024)
  11. 11. Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine. Shinichi Ogawa; Tatsuhiro Sakamoto; Ryota Matsuoka; Kantaro Ishitsuka (+14 著者) Shigeru Chiba
      Cancer reports (Hoboken, N.J.) 7: e1938 (2024) Semantic Scholar
  12. 12. [Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation]. Haruka Momose; Naoki Kurita; Hidekazu Nishikii; Nozomi Yusa (+11 著者) Shigeru Chiba
      [Rinsho ketsueki] The Japanese journal of clinical hematology 65: 35 (2024) Semantic Scholar
  13. 13. A longitudinal analysis of paroxysmal nocturnal haemoglobinuria-type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan. Ken Ishiyama; Yuji Yonemura; Tatsuya Kawaguchi; Kohei Hosokawa (+12 著者) Shinji Nakao
      British journal of haematology 203: 468 (2023) Semantic Scholar
  14. 14. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. Tatsuhiro Sakamoto; Naoshi Obara; Yumiko Maruyama; Takayasu Kato (+7 著者) Shigeru Chiba
      European journal of haematology 111: 768 (2023) Semantic Scholar
  15. 15. 発作性夜間ヘモグロビン尿症患者におけるラブリズマブ高濃度製剤の安全性、有効性に関する検討 西脇 嘉一; 臼杵 憲祐; 池添 隆之; 石山 謙 (+6 著者) 西村 純一
      日本血液学会学術集会 85回: 576 (2023)
  16. 16. Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial. Naoki Kurita; Hidekazu Nishikii; Yumiko Maruyama; Yasuhito Suehara (+13 著者) Shigeru Chiba
      Annals of hematology 102: 2895 (2023) Semantic Scholar
  17. 17. Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan. Kensuke Usuki; Takayuki Ikezoe; Ken Ishiyama; Yoshinobu Kanda (+5 著者) Jun-Ichi Nishimura
      International journal of hematology 118: 311 (2023) Semantic Scholar
  18. 18. Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial. Alexander Röth; Satoshi Ichikawa; Yoshikazu Ito; Jin Seok Kim (+14 著者) Jun-Ichi Nishimura
      European journal of haematology 111: 300 (2023) Semantic Scholar
  19. 19. Triple-negative Thrombocythemia and Subsequent Acute Lymphoblastic Leukemia with Additional Somatic Mutations Yuri Tsuboi; Tatsuhiro Sakamoto; Kenichi Makishima; Yasuhito Suehara (+9 著者) Mamiko Sakata-Yanagimoto
      Internal medicine (Tokyo, Japan) 62: 1527 (2023) Semantic Scholar
  20. 20. Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia. Yoshinobu Kanda; Kensuke Usuki; Mitsuhiro Inagaki; Akiko Ohta (+9 著者) Hirohito Yamazaki
      International journal of hematology 117: 660 (2023) Semantic Scholar
1 2 3 … 7

書籍等出版物情報はまだありません。

講演・口頭発表情報はまだありません。

 638 total views